Quick Answer
A 2026 RCT in the Journal of Pineal Research enrolled 202 older adults across three European cities and found that higher naturalistic daytime light exposure was associated with 3x higher odds of good sleep quality (OR = 3.00, 95% CI: 1.16-8.11, p = 0.03). Timing mattered: starting light supplementation before 11 AM was linked to higher daytime activity and less sleep-wake fragmentation. Evidence is Promising - robust signal, population specificity requires caution before extrapolating to younger adults.
At a Glance
Why Hiya chose this study
Light is usually discussed in sleep science from the wrong direction: how to avoid it at night. This paper asked a different question. If nighttime light disrupts sleep, does daytime light protect it? And if so, can a simple lamp intervention shift those odds meaningfully in community-dwelling older adults?
Our editor Hiya Aidasani flagged this paper because the Journal of Pineal Research is one of the most rigorous venues for circadian and melatonin research. The ENLIGHTENme trial was also a genuine RCT, not an observational study - which gave the findings more weight than the majority of light-and-sleep literature, which tends to be correlational.
The population was specific (older adults in European cities), and Hiya notes the limitations clearly in the section below. But the mechanism being tested - the cortisol-melatonin axis as a mediator of light-to-sleep quality - is not age-specific. That made the paper worth covering despite the population mismatch.
Why this paper was selected for the Digest
What the study did
The ENLIGHTENme trial was a multi-site RCT conducted across Amsterdam, Bologna, and Tartu from February 2023 to February 2024. Researchers enrolled 202 adults aged 63 to 92 years, with women making up 72% of the sample. After a 2-week baseline assessment period, participants were randomised to either a 12-week light supplementation arm (using a lamp delivering greater than 8,000 melanopic equivalent daylight illuminance, or melanopic EDI) or a control arm. A 2-week post-intervention assessment followed.
The key distinction from most light studies: this was self-administered. Participants used the lamps in their own homes, on their own schedules. The researchers tracked not just whether people used the lamps, but when - and that timing question turned out to be the most informative finding.
Naturalistic light exposure (measured by actigraphy-derived melanopic metrics throughout the study) was stratified into low, moderate, and high groups. Sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI), a validated 7-component instrument where scores above 5 indicate poor sleep.
What the findings showed
Three independent findings emerged across the light-exposure and timing analyses.
1. More daytime light - better sleep quality
The low-light group had a median PSQI score of 7.0 - firmly in the "poor sleep" range. The moderate-light group came in at 5.0, and the high-light group at 4.0, crossing the clinical threshold into "good sleep." The odds of reporting good sleep quality were 3 times higher in the high-light group compared to the low-light group (OR = 3.00, 95% CI: 1.16-8.11, p = 0.03).
| Light exposure group | Median PSQI score | PSQI range (IQR) | Sleep classification |
|---|---|---|---|
| Low | 7.0 | 4.0-10.0 | Poor sleep quality |
| Moderate | 5.0 | 3.0-7.0 | Borderline |
| High | 4.0 | 3.0-7.0 | Good sleep quality |
2. Timing mattered as much as intensity
Among participants who used the light supplementation lamp, those who started before 10:57 AM showed meaningfully better outcomes than those who started later. The early-start group had significantly higher daytime activity levels (p = 0.04) and significantly lower sleep-wake fragmentation, measured by intradaily variability (p = 0.05).
This aligns with what the cortisol axis predicts: light before 11 AM is acting on the morning cortisol awakening response at its most responsive window. Starting later may partially miss that window, reducing the downstream benefit for nighttime sleep architecture.
"Individuals with higher light exposure showed significantly higher daytime levels of activity, experienced more consolidated periods of wakefulness, and reported higher subjective sleep quality compared to those with lower light exposure." - Constantino et al., Journal of Pineal Research, 2026
3. Light exposure and metabolic health tracked together
Participants with lower daytime light exposure showed a higher incidence of metabolic conditions. The association between higher light exposure and healthy metabolic status was statistically significant (beta = 1.38 x 10^-4, p = 0.01). This is consistent with emerging evidence that the cortisol-light axis regulates not just sleep but insulin sensitivity, appetite hormones, and inflammatory markers.
The paper does not establish causality on the metabolic finding - it is an association, not an intervention result for metabolism specifically. But the direction matches a growing body of work linking circadian disruption to metabolic syndrome.
The mechanism: how morning light shapes nighttime sleep
The paper itself identifies the cortisol axis as the most likely mediator, drawing on the broader literature rather than measuring cortisol directly in this study.
The sequence works like this. Morning bright light hits the retina and activates the retinohypothalamic tract, which signals the suprachiasmatic nucleus (SCN) - the brain's master clock. The SCN then suppresses residual melatonin secretion from the pineal gland and triggers cortisol release from the adrenal cortex. This morning cortisol rise drives alertness, supports daytime physical activity (M10), and - critically - sets the amplitude of the day-night contrast in your hormonal profile.
When that morning signal is weak (because you work indoors, live in a high-rise, or skip outdoor time), the cortisol peak is blunted. The day-night contrast flattens. The melatonin rise in the evening becomes less pronounced and less well-timed. The result: lighter, more fragmented sleep - exactly what the low-light group showed in PSQI scores.
Early light does not just start your day. It sets the circadian schedule that determines the quality of your night.
Verdict: Promising
Strong signal from a Q1-journal RCT with 202 participants and a validated sleep outcome measure. The effect size is clinically meaningful (OR = 3.00 is a large odds ratio in behavioural research). Rated Promising rather than Established because the population is specific to older adults, women make up 72% of the sample, the light supplementation was self-directed and not personalised to individual chronotypes, and objective light data was not collected continuously throughout the 12-week period. Replication in younger, more diverse populations is needed before this finding can be rated Established.
Study limitations
Limitations (Hiya's analysis)
What This Means Tonight
The practical takeaway for your sleep routine
Your brain uses the morning light signal to calibrate the cortisol curve that sets up your entire day and, downstream, your sleep quality that night. When you spend your mornings inside (which most urban professionals do), that calibration is weak. The ENLIGHTENme data quantifies what a stronger signal produces: a 3-point drop in PSQI and 3x better odds of good sleep.
The simplest implementation: 20 minutes outside before 11 AM. No specialist lamp required. Walk to the office, sit near a window at breakfast, or step outside during your first break. The timing is the variable that matters most - starting before 11 AM showed significantly better outcomes than later exposure at the same intensity.
This is a behavioural complement to supplementation, not a replacement for it. Night Reboot works on the stress-recovery and slow-wave sleep pathways later in the cycle. But neither supplements nor habits work in isolation - the cortisol curve that morning light shapes is the same axis that determines how deeply your nervous system can downregulate by 10 PM.
Frequently Asked Questions
Does daytime light exposure actually improve sleep quality?
A 2026 RCT (ENLIGHTENme, Journal of Pineal Research) in 202 older adults across 3 European cities found that those with higher naturalistic daytime light exposure had 3x higher odds of reporting good sleep quality (OR = 3.00, 95% CI: 1.16-8.11, p = 0.03). Low-light participants had a median PSQI score of 7.0 (poor sleep); high-light participants had 4.0 (good sleep). Evidence rated Promising.
What time of day is best to get natural light for better sleep?
In the ENLIGHTENme RCT, participants who started light supplementation before 10:57 AM had significantly higher daytime activity (p = 0.04) and less fragmented sleep-wake rhythms (p = 0.05). The underlying mechanism is the cortisol awakening response: morning light before 11 AM hits the response at its most sensitive window.
How does light exposure affect the cortisol-melatonin axis?
Morning bright light activates the retinohypothalamic tract, which signals the SCN to suppress residual melatonin and stimulate cortisol release from the adrenal cortex. This morning cortisol peak drives daytime alertness. As light diminishes in the evening, cortisol drops and melatonin rises. Insufficient daytime light blunts this contrast, producing lighter and more fragmented sleep.
Does this study apply to younger adults and urban Indians?
The study enrolled adults aged 63 to 92, so direct extrapolation requires caution. The cortisol-melatonin mechanism is universal, but age-related changes in circadian amplitude mean the effect sizes may differ in younger populations. Urban Indians face a highly relevant version of this problem: indoor sedentary work and high-rise buildings restrict daytime light in ways that parallel the low-light group in this study.
What is a PSQI score and what does it measure?
The Pittsburgh Sleep Quality Index (PSQI) is a validated 7-component questionnaire measuring subjective sleep quality, latency, duration, efficiency, disturbances, sleep medication use, and daytime dysfunction. A score of 5 or below indicates good sleep quality; above 5 indicates poor sleep quality. In this study, the low-light group scored 7.0 and the high-light group scored 4.0 on the PSQI.
Get the Digest every Monday
One email a week. Three to five peer-reviewed sleep papers, each rated Established, Promising, or Too Early, with the effect sizes, the limitations, and what each one changes for you.
We publish the papers that go against us as readily as the ones that support us. No sales sequence, no daily wellness tips, unsubscribe in one click.
Published by Zandra Life Sciences Pvt. Ltd., makers of REINCARN Night Reboot. Commercial interest disclosed on every issue. · RSS feed
Source
- Constantino DB, van der Veen DR, et al. "ENLIGHTENme: Translating the Benefits of Self-Administered Daytime Light Supplementation to Older Adults in the Real World." Journal of Pineal Research. 2026;78:e70174. doi: 10.1111/jpi.70174. PMID: 42685789.
Publisher's Note
This Digest is published by Zandra Life Sciences Pvt. Ltd., which makes REINCARN Night Reboot, a melatonin-free sleep supplement. That is a commercial interest and we disclose it on every issue.
Nothing in this issue should be read as evidence for Night Reboot. The studies covered here tested single interventions in specific populations. Our formula combines seven ingredients that have been studied individually and has not been tested as a complete formula in a trial.
If you want to know what is in it and what each ingredient is dosed at, the formula page lists every ingredient with its published study. See the formula →
This content is for informational purposes only and does not constitute medical advice. Night Reboot is a food supplement, not a medicine. Consult a healthcare professional before use. Contains KSM-66 Ashwagandha - exercise caution if you have a thyroid condition or take thyroid medication. Adults 18+ only. Corrections: reincarn@zandralifesciences.com